MLchartDataset catalogue

KRN7000

Term · Oncology and biomedicine · MLC-T-ONC-004669

A drug being studied in the treatment of cancer. It is a biological response modifier that is a type of glycosphingolipid or agelasphin.

Table 1. Record
IdentifierMLC-T-ONC-004669
FieldOncology and biomedicine
ReferencesNCI Dictionary of Cancer Terms
Record as JSON 
{
  "id": "MLC-T-ONC-004669",
  "term": "KRN7000",
  "field": "Oncology and biomedicine",
  "definition": "A drug being studied in the treatment of cancer. It is a biological response modifier that is a type of glycosphingolipid or agelasphin.",
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/krn7000/"
}

Record 9,839 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.